Assignee
NEUBASE THERAPEUTICS INC
US·1 granted patent·4 pending applications·1 citations·filing 2021–2023
Top patents by PatentIndex Score
5 records- 0176US11603530B2Modified peptide nucleic acid compositionsNEUBASE THERAPEUTICS INC·Filed 2021·Granted Mar 14, 2023·1 cites·1 claims
- 0262US2023174985A1Modified peptide nucleic acid compositionsNEUBASE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0354US2021309997A1Modified peptide nucleic acid compositionsNEUBASE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0444US2024132628A1Oligonucleotide analogue therapeutics for treatment of neuromuscular diseaseNEUBASE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0540US2025360158A1Oligonucleotide analogue formulationsNEUBASE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →